POPULARITY
3 episodes with series women in science health
3 episodes with series women in science health
3 episodes with series women in science health
Catherine Yeung, Pharm.D., Ph.D., M.P.H., discusses groundbreaking advancements in kidney-on-a-chip technology, emphasizing its potential to revolutionize human health. She delves into the role of environmental toxins, such as okra toxin A, microplastics, and plasticizers, in contributing to chronic kidney disease, particularly in regions with specific dietary practices. Yeung also addresses the challenges of replicating adult kidney cells from stem cells, which often retain a fetal phenotype, and underscores the value of stem cell-derived models for genetic manipulation and disease research. Additionally, she highlights the increased risk of kidney stones in astronauts post-spaceflight and the broader implications of organ-on-chip technology for studying therapies and diseases. Series: "Women in Science" [Health and Medicine] [Science] [Show ID: 39458]
Catherine Yeung, Pharm.D., Ph.D., M.P.H., discusses groundbreaking advancements in kidney-on-a-chip technology, emphasizing its potential to revolutionize human health. She delves into the role of environmental toxins, such as okra toxin A, microplastics, and plasticizers, in contributing to chronic kidney disease, particularly in regions with specific dietary practices. Yeung also addresses the challenges of replicating adult kidney cells from stem cells, which often retain a fetal phenotype, and underscores the value of stem cell-derived models for genetic manipulation and disease research. Additionally, she highlights the increased risk of kidney stones in astronauts post-spaceflight and the broader implications of organ-on-chip technology for studying therapies and diseases. Series: "Women in Science" [Health and Medicine] [Science] [Show ID: 39458]
Catherine Yeung, Pharm.D., Ph.D., M.P.H., discusses groundbreaking advancements in kidney-on-a-chip technology, emphasizing its potential to revolutionize human health. She delves into the role of environmental toxins, such as okra toxin A, microplastics, and plasticizers, in contributing to chronic kidney disease, particularly in regions with specific dietary practices. Yeung also addresses the challenges of replicating adult kidney cells from stem cells, which often retain a fetal phenotype, and underscores the value of stem cell-derived models for genetic manipulation and disease research. Additionally, she highlights the increased risk of kidney stones in astronauts post-spaceflight and the broader implications of organ-on-chip technology for studying therapies and diseases. Series: "Women in Science" [Health and Medicine] [Science] [Show ID: 39458]
Catherine Yeung, Pharm.D., Ph.D., M.P.H., discusses groundbreaking advancements in kidney-on-a-chip technology, emphasizing its potential to revolutionize human health. She delves into the role of environmental toxins, such as okra toxin A, microplastics, and plasticizers, in contributing to chronic kidney disease, particularly in regions with specific dietary practices. Yeung also addresses the challenges of replicating adult kidney cells from stem cells, which often retain a fetal phenotype, and underscores the value of stem cell-derived models for genetic manipulation and disease research. Additionally, she highlights the increased risk of kidney stones in astronauts post-spaceflight and the broader implications of organ-on-chip technology for studying therapies and diseases. Series: "Women in Science" [Health and Medicine] [Science] [Show ID: 39458]
Catherine Yeung, Pharm.D., Ph.D., M.P.H., discusses groundbreaking advancements in kidney-on-a-chip technology, emphasizing its potential to revolutionize human health. She delves into the role of environmental toxins, such as okra toxin A, microplastics, and plasticizers, in contributing to chronic kidney disease, particularly in regions with specific dietary practices. Yeung also addresses the challenges of replicating adult kidney cells from stem cells, which often retain a fetal phenotype, and underscores the value of stem cell-derived models for genetic manipulation and disease research. Additionally, she highlights the increased risk of kidney stones in astronauts post-spaceflight and the broader implications of organ-on-chip technology for studying therapies and diseases. Series: "Women in Science" [Health and Medicine] [Science] [Show ID: 39458]
Catherine Yeung, Pharm.D., Ph.D., M.P.H., discusses groundbreaking advancements in kidney-on-a-chip technology, emphasizing its potential to revolutionize human health. She delves into the role of environmental toxins, such as okra toxin A, microplastics, and plasticizers, in contributing to chronic kidney disease, particularly in regions with specific dietary practices. Yeung also addresses the challenges of replicating adult kidney cells from stem cells, which often retain a fetal phenotype, and underscores the value of stem cell-derived models for genetic manipulation and disease research. Additionally, she highlights the increased risk of kidney stones in astronauts post-spaceflight and the broader implications of organ-on-chip technology for studying therapies and diseases. Series: "Women in Science" [Health and Medicine] [Science] [Show ID: 39458]
Curious about what happens to our cells as we age and how it affects our health? Shiri Gur-Cohen explores the role of tiny chemical tags on our DNA, like methylation, in influencing our healing and overall well-being. Gur-Cohen discusses how these tags might be shaped by our body's systems, such as the lymphatic system, and could even help repair or regenerate various parts of our body. Gur-Cohen proposes that uncovering these processes could lead to innovative ways to slow aging or boost our body's natural healing capabilities. Series: "Women in Science" [Health and Medicine] [Science] [Show ID: 39979]
Curious about what happens to our cells as we age and how it affects our health? Shiri Gur-Cohen explores the role of tiny chemical tags on our DNA, like methylation, in influencing our healing and overall well-being. Gur-Cohen discusses how these tags might be shaped by our body's systems, such as the lymphatic system, and could even help repair or regenerate various parts of our body. Gur-Cohen proposes that uncovering these processes could lead to innovative ways to slow aging or boost our body's natural healing capabilities. Series: "Women in Science" [Health and Medicine] [Science] [Show ID: 39979]
Curious about what happens to our cells as we age and how it affects our health? Shiri Gur-Cohen explores the role of tiny chemical tags on our DNA, like methylation, in influencing our healing and overall well-being. Gur-Cohen discusses how these tags might be shaped by our body's systems, such as the lymphatic system, and could even help repair or regenerate various parts of our body. Gur-Cohen proposes that uncovering these processes could lead to innovative ways to slow aging or boost our body's natural healing capabilities. Series: "Women in Science" [Health and Medicine] [Science] [Show ID: 39979]
Curious about what happens to our cells as we age and how it affects our health? Shiri Gur-Cohen explores the role of tiny chemical tags on our DNA, like methylation, in influencing our healing and overall well-being. Gur-Cohen discusses how these tags might be shaped by our body's systems, such as the lymphatic system, and could even help repair or regenerate various parts of our body. Gur-Cohen proposes that uncovering these processes could lead to innovative ways to slow aging or boost our body's natural healing capabilities. Series: "Women in Science" [Health and Medicine] [Science] [Show ID: 39979]
Curious about what happens to our cells as we age and how it affects our health? Shiri Gur-Cohen explores the role of tiny chemical tags on our DNA, like methylation, in influencing our healing and overall well-being. Gur-Cohen discusses how these tags might be shaped by our body's systems, such as the lymphatic system, and could even help repair or regenerate various parts of our body. Gur-Cohen proposes that uncovering these processes could lead to innovative ways to slow aging or boost our body's natural healing capabilities. Series: "Women in Science" [Health and Medicine] [Science] [Show ID: 39979]
Curious about what happens to our cells as we age and how it affects our health? Shiri Gur-Cohen explores the role of tiny chemical tags on our DNA, like methylation, in influencing our healing and overall well-being. Gur-Cohen discusses how these tags might be shaped by our body's systems, such as the lymphatic system, and could even help repair or regenerate various parts of our body. Gur-Cohen proposes that uncovering these processes could lead to innovative ways to slow aging or boost our body's natural healing capabilities. Series: "Women in Science" [Health and Medicine] [Science] [Show ID: 39979]
Curious about what happens to our cells as we age and how it affects our health? Shiri Gur-Cohen explores the role of tiny chemical tags on our DNA, like methylation, in influencing our healing and overall well-being. Gur-Cohen discusses how these tags might be shaped by our body's systems, such as the lymphatic system, and could even help repair or regenerate various parts of our body. Gur-Cohen proposes that uncovering these processes could lead to innovative ways to slow aging or boost our body's natural healing capabilities. Series: "Women in Science" [Health and Medicine] [Science] [Show ID: 39979]
Karen Christman and Marianna Alperin discuss the newest discoveries and cutting-edge techniques for pro-regenerative biomaterials for heart and skeletal muscle with applications to cardiovascular disease and pelvic floor disorders. Series: "Women in Science" [Health and Medicine] [Science] [Show ID: 36848]
Karen Christman and Marianna Alperin discuss the newest discoveries and cutting-edge techniques for pro-regenerative biomaterials for heart and skeletal muscle with applications to cardiovascular disease and pelvic floor disorders. Series: "Women in Science" [Health and Medicine] [Science] [Show ID: 36848]
Karen Christman and Marianna Alperin discuss the newest discoveries and cutting-edge techniques for pro-regenerative biomaterials for heart and skeletal muscle with applications to cardiovascular disease and pelvic floor disorders. Series: "Women in Science" [Health and Medicine] [Science] [Show ID: 36848]
Karen Christman and Marianna Alperin discuss the newest discoveries and cutting-edge techniques for pro-regenerative biomaterials for heart and skeletal muscle with applications to cardiovascular disease and pelvic floor disorders. Series: "Women in Science" [Health and Medicine] [Science] [Show ID: 36848]
Karen Christman and Marianna Alperin discuss the newest discoveries and cutting-edge techniques for pro-regenerative biomaterials for heart and skeletal muscle with applications to cardiovascular disease and pelvic floor disorders. Series: "Women in Science" [Health and Medicine] [Science] [Show ID: 36848]
Karen Christman and Marianna Alperin discuss the newest discoveries and cutting-edge techniques for pro-regenerative biomaterials for heart and skeletal muscle with applications to cardiovascular disease and pelvic floor disorders. Series: "Women in Science" [Health and Medicine] [Science] [Show ID: 36848]
Karen Christman and Marianna Alperin discuss the newest discoveries and cutting-edge techniques for pro-regenerative biomaterials for heart and skeletal muscle with applications to cardiovascular disease and pelvic floor disorders. Series: "Women in Science" [Health and Medicine] [Science] [Show ID: 36848]
Karen Christman and Marianna Alperin discuss the newest discoveries and cutting-edge techniques for pro-regenerative biomaterials for heart and skeletal muscle with applications to cardiovascular disease and pelvic floor disorders. Series: "Women in Science" [Health and Medicine] [Science] [Show ID: 36848]
Karen Christman and Marianna Alperin discuss the newest discoveries and cutting-edge techniques for pro-regenerative biomaterials for heart and skeletal muscle with applications to cardiovascular disease and pelvic floor disorders. Series: "Women in Science" [Health and Medicine] [Science] [Show ID: 36848]
Karen Christman and Marianna Alperin discuss the newest discoveries and cutting-edge techniques for pro-regenerative biomaterials for heart and skeletal muscle with applications to cardiovascular disease and pelvic floor disorders. Series: "Women in Science" [Health and Medicine] [Science] [Show ID: 36848]
Karen Christman and Marianna Alperin discuss the newest discoveries and cutting-edge techniques for pro-regenerative biomaterials for heart and skeletal muscle with applications to cardiovascular disease and pelvic floor disorders. Series: "Women in Science" [Health and Medicine] [Science] [Show ID: 36848]
Karen Christman and Marianna Alperin discuss the newest discoveries and cutting-edge techniques for pro-regenerative biomaterials for heart and skeletal muscle with applications to cardiovascular disease and pelvic floor disorders. Series: "Women in Science" [Health and Medicine] [Science] [Show ID: 36848]
Karen Christman and Marianna Alperin discuss the newest discoveries and cutting-edge techniques for pro-regenerative biomaterials for heart and skeletal muscle with applications to cardiovascular disease and pelvic floor disorders. Series: "Women in Science" [Health and Medicine] [Science] [Show ID: 36848]
Karen Christman and Marianna Alperin discuss the newest discoveries and cutting-edge techniques for pro-regenerative biomaterials for heart and skeletal muscle with applications to cardiovascular disease and pelvic floor disorders. Series: "Women in Science" [Health and Medicine] [Science] [Show ID: 36848]
The UCLA Broad Stem Cell Research Center's Dr. Gay Crooks describes research into a treatment for COVID-19 made possible by funding from California's Stem Cell Agency - CIRM. Series: "Women in Science" [Health and Medicine] [Science] [Show ID: 36461]
Stanford University's Helen Blau describes research into a treatment for COVID-19 made possible by funding from California's Stem Cell Agency - CIRM. Series: "Women in Science" [Health and Medicine] [Science] [Show ID: 36462]
Stanford University's Helen Blau describes research into a treatment for COVID-19 made possible by funding from California's Stem Cell Agency - CIRM. Series: "Women in Science" [Health and Medicine] [Science] [Show ID: 36462]
The UCLA Broad Stem Cell Research Center's Dr. Brigitte Gomperts describes research into a treatment for COVID-19 utilizing lung organoids derived from pluripotent stem cells that is made possible by funding from California's Stem Cell Agency - CIRM. Series: "Women in Science" [Health and Medicine] [Science] [Show ID: 36460]
The UCLA Broad Stem Cell Research Center's Dr. Brigitte Gomperts describes research into a treatment for COVID-19 utilizing lung organoids derived from pluripotent stem cells that is made possible by funding from California's Stem Cell Agency - CIRM. Series: "Women in Science" [Health and Medicine] [Science] [Show ID: 36460]
The UCLA Broad Stem Cell Research Center's Dr. Gay Crooks describes research into a treatment for COVID-19 made possible by funding from California's Stem Cell Agency - CIRM. Series: "Women in Science" [Health and Medicine] [Science] [Show ID: 36461]
Dr. Nadine Burke Harris, California's first-ever Surgeon General , is dedicated to changing the way our society deals with the public health crisis of childhood trauma. An overwhelming scientific consensus demonstrates that cumulative adversity, particularly during critical and sensitive developmental periods, is a root cause to some of the most harmful, persistent and expensive health challenges facing our nation. In this keynote address at the 2020 CIRM Grantee Meeting, Dr. Burke Harris explains the science and solutions. Series: "Women in Science" [Health and Medicine] [Show ID: 36328]
Delve into the realms of predatory superbugs with infectious disease epidemiologist Steffanie Strathdee and her husband, psychologist Thomas Patterson. This is an incredible story of Strathdee's fight to save her husband's life, which led her to rediscover a forgotten treatment for antibiotic-resistant bacteria. This unprecedented treatment saved Patterson's life as well as several others and helped launch the Center for Innovative Phage Applications and Therapeutics (IPATH) at UC San Diego, the first phage therapy center in North America. Series: "Women in Science" [Health and Medicine] [Humanities] [Show ID: 34410]
Dr. Christine Cassel, Presidential Chair in the Department of Medicine at UCSF, talks with Dr. Wachter about her career in healthcare and policy, including her burgeoning interests in new technologies and their impact on the practice of medicine. Cassel has had a storied career in a several areas in healthcare, including geriatrics, ethics, and health policy. She served as chair of the Department of Geriatrics at Mt. Sinai, the Dean at Oregon Health Sciences University, and the CEO of two major national organizations: the National Quality Forum and the American Board of Internal Medicine. While at ABIM, she launched campaigns to promote professionalism in medicine and cost consciousness (“Choosing Wisely”). Before coming to UCSF, she was the planning dean for Kaiser Permanente's new medical school in Southern California. She also served on President Obama's Council on Science and Technology. Series: "Women in Science" [Health and Medicine] [Business] [Show ID: 34468]
Dr. Rebecca Berman was recently recruited to UCSF to direct the internal medicine residency program, generally considered to be one of the nation's finest. Dr. Berman comes to UCSF from Harvard, where she directed the primary care residency program at Brigham & Womens Hospital. In the interview, Dr. Berman discusses her upbringing, her longstanding commitment to social justice and health equity, her approach to mentoring and career development, and her view of how medical training needs to evolve to meet the needs of our trainees and patients. Series: "Women in Science" [Health and Medicine] [Business] [Show ID: 34340]
© 2020-2026 Ivy Podcast Discovery LLC
